홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

2,6-Lutidine → {3-[3-(2-{Benzyl-[(R)-2-(8-benzyloxy-2-oxo-1,2-dihydroquinolin-5-yl)-2-(tert-butyldimethylsilanyloxy)ethyl]amino}ethyl)phenylcarbamoyl]-propyl}methylcarbamic Acid tert-Butyl Ester

HRID 2412250
인쇄

반응식

HRID 2412250 반응식
[C:1]([O:5][C:6](CNCCCC(O)=O)=[O:7])([CH3:4])([CH3:3])[CH3:2].[NH2:16][C:17]1[CH:18]=[C:19]([CH2:23][CH2:24][N:25]([CH2:55][C:56]2[CH:61]=[CH:60][CH:59]=[CH:58][CH:57]=2)[CH2:26][C@@H:27]([C:36]2[CH:45]=[CH:44][C:43]([O:46][CH2:47][C:48]3[CH:53]=[CH:52][CH:51]=[CH:50][CH:49]=3)=[C:42]3[C:37]=2[CH:38]=[CH:39][C:40](=[O:54])[NH:41]3)[O:28][Si:29]([C:32]([CH3:35])([CH3:34])[CH3:33])([CH3:31])[CH3:30])[CH:20]=[CH:21][CH:22]=1.[N:62]1[C:67](C)=[CH:66][CH:65]=[CH:64][C:63]=1C.Cl.CN(C)CCCN=C=NCC.[OH:82]N1C2N=CC=CC=2N=N1>CN(C=O)C.[Cl-].[Li+].C(Cl)Cl.O>[C:1]([O:5][C:6](=[O:7])[N:62]([CH2:63][CH2:64][CH2:65][C:66](=[O:82])[NH:16][C:17]1[CH:22]=[CH:21][CH:20]=[C:19]([CH2:23][CH2:24][N:25]([CH2:55][C:56]2[CH:61]=[CH:60][CH:59]=[CH:58][CH:57]=2)[CH2:26][C@@H:27]([C:36]2[CH:45]=[CH:44][C:43]([O:46][CH2:47][C:48]3[CH:53]=[CH:52][CH:51]=[CH:50][CH:49]=3)=[C:42]3[C:37]=2[CH:38]=[CH:39][C:40](=[O:54])[NH:41]3)[O:28][Si:29]([C:32]([CH3:33])([CH3:35])[CH3:34])([CH3:30])[CH3:31])[CH:18]=1)[CH3:67])([CH3:4])([CH3:3])[CH3:2]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

10

반응물 5

HCID 79372,6-LutidineHCID 181649HOAtHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 216437024-[(2-tert-Butoxy-2-oxoethyl)amino]butanoic acidHCID 667816275-[(R)-2-{[2-(3-Aminophenyl)ethyl]benzylamino}-1-(tert-butyl-dimethylsilanyloxy)ethyl]-8-benzyloxy-1H-quinolin-2-one

생성물 1

HCID 66781581
{3-[3-(2-{Benzyl-[(R)-2-(8-benzyloxy-2-oxo-1,2-dihydroquinolin-5-yl)-2-(tert-butyldimethylsilanyloxy)ethyl]amino}ethyl)phenylcarbamoyl]-propyl}methylcarbamic Acid tert-Butyl Ester

시약·촉매·용매 4

HCID 962Water용매HCID 6228Dimethylformamide용매2회HCID 6344Dichloromethane용매HCID 433294Lithium Chloride용매

실험 절차

To a stirred solution of 4-(tert-butoxycarbonylmethylamino)butyric acid (72.0 mg, 0.331 mmol); 5-[(R)-2-{[2-(3-aminophenyl)ethyl]benzylamino}-1-(tert-butyl-dimethylsilanyloxy)ethyl]-8-benzyloxy-1H-quinolin-2-one (210 mg, 0.331 mmol); 2,6-lutidine (46.5 μL, 0.398 mmol); and N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (69.8 mg, 0.364 mmol) in DMF (3 mL) at room temperature was added a solution of 1-hydroxy-7-azabenzotriazole in DMF (0.5 M, 0.729 mL, 0.364 mmol). The resulting mixture was stirred at room temperature overnight. LC-MS (Method 2-90) showed product was present (Rt 4.56 min; m/z 833.6 [M+H]+). Water was added and this mixture was diluted with aqueous 10% lithium chloride solution and DCM. The layers were separated and the organic layer was washed with aqueous 10% lithium chloride solution (2×), dried over sodium sulfate, filtered and concentrated under reduced pressure. The residue was further concentrated under high vacuum to give the title compound (containing a minor amount of DMF), which was used in the next reaction without further purification.

후처리

  1. customThe layers were separated
  2. washthe organic layer was washed with aqueous 10% lithium chloride solution (2×)
  3. dry with materialdried over sodium sulfate
  4. filtrationfiltered
  5. concentrationconcentrated under reduced pressure
  6. concentrationThe residue was further concentrated under high vacuum

출처 및 근거

ORD 기록
ord-b6e111a0fec24c45b09d69a9d69a8c00
출처 데이터셋
uspto-grants-2014_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08816088B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트